Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery
NCT ID: NCT01303250
Last Updated: 2015-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
31 participants
INTERVENTIONAL
2011-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that patients in the intervention group will need less fluid administration be optimal hemodynamic stabilized.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
A balanced hydroxyethyl starch 130/0.4 will be used
balanced 6% hydroxyethylstarch 130/0.4
Fluid administration and optimization based on cardiac output findings during surgery.
Group 2
A balanced crystalloid will be used
balanced crystalloid
Fluid administration and optimization based on cardiac output findings during surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
balanced 6% hydroxyethylstarch 130/0.4
Fluid administration and optimization based on cardiac output findings during surgery.
balanced crystalloid
Fluid administration and optimization based on cardiac output findings during surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minimum age 18 years
* informed consent
Exclusion Criteria
* history of coagulation disorders
* intracranial hemorrhage
* patients with severe cardiovascular or respiratory disorders
* renal insufficiency
* severe liver diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fresenius Kabi
INDUSTRY
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugo Van Aken, Prof. MD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesia and Intensive Care, University Hospital Muenster
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Muenster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-017595-25
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
04-AnIt-09
Identifier Type: OTHER
Identifier Source: secondary_id
UKM09_0031
Identifier Type: -
Identifier Source: org_study_id